Legal & General Group’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-27,556
| Closed | -$2.96M | – | 3591 |
|
|
2023
Q1 | $2.96M | Buy |
27,556
+17,407
| +172% | +$1.87M | ﹤0.01% | 1692 |
|
|
2022
Q4 | $1.12M | Buy |
10,149
+4,079
| +67% | +$449K | ﹤0.01% | 2127 |
|
|
2022
Q3 | $358K | Buy |
6,070
+457
| +8% | +$27K | ﹤0.01% | 2430 |
|
|
2022
Q2 | $158K | Buy |
5,613
+389
| +7% | +$11K | ﹤0.01% | 2718 |
|
|
2022
Q1 | $197K | Sell |
5,224
-873
| -14% | -$32.9K | ﹤0.01% | 2672 |
|
|
2021
Q4 | $241K | Buy |
6,097
+5,146
| +541% | +$203K | ﹤0.01% | 2645 |
|
|
2021
Q3 | $23K | Buy |
951
+49
| +5% | +$1.19K | ﹤0.01% | 3236 |
|
|
2021
Q2 | $22K | Buy |
+902
| New | +$22K | ﹤0.01% | 3272 |
|